JPRN-UMIN000000513
Completed
Phase 2
Prospecitve study of radiotherapy without surgery after AC followed by weekly paclitaxel and trastuzumab for inflammatory breast cancer with HER2 over expression - Prospecitve study of radiotherapy without surgery after AC followed by weekly paclitaxel and trastuzumab for inflammatory breast cancer with HER2 over expression
Saitama Breast Cancer Clinical Study Group (SBCCSG)0 sites20 target enrollmentNovember 6, 2006
ConditionsInflammatory breast cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Inflammatory breast cancer
- Sponsor
- Saitama Breast Cancer Clinical Study Group (SBCCSG)
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. severe complication 2\. suspicious of infection 3\. past history of allergic reaction to cremophor EL (polyoxyethylated castor oil) or polysorbate 4\. pregnant or lactating women 5\. doctor's decision for exclusion
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
Prospective observational study of radiotherapy with respiratory migration countermeasures for breast cancerJPRN-UMIN000045576Kagawa University Hospital30
Recruiting
Phase 2
A Feasibility Study of definitive radiotherapy with FOLFOX for Esophageal CancerEsophageal cancerEsophageal cancer, FOLFOX, chemoradiotherapyD004938JPRN-jRCTs031220219Miura Akinori20
Recruiting
Phase 1
Phase I/II clinical trial of radical radiotherapy using carbon-ion beams for early breast cancerJPRN-UMIN000010848ational Institute of Radiological Sciences20
Recruiting
N/A
A prospective study of salvage radiotherapy combined with horrmone therapy for high-risk recurrent prostate cancer after radical prostatectomyRecurrent prostate cancer after radical prostatectomyJPRN-UMIN000030864Department of Urology, Nara Medical University100
Completed
N/A
Investigation on radiotherapy treatment effect using perfusion and diffusion-weighted MR imagingtumorJPRN-UMIN000014439Kyoto Univerisity Hospital